Pharma Commercial Mock
← All views·CI feed·API docs
AASCO
Meeting Library
AACR Annual Meeting 2026 · San Diego, CA
17 shown of 8,726 total abstracts
  1. Abstract 96822026-04-04 · 14:45 CT · S406
    Quality of life outcomes with Keytruda in patients with metastatic melanoma
    M. Krop, H. Borghaei · Royal Marsden Hospital
    Oral Abstract SessionMelanoma📄🖼️🎬
  2. Abstract 104532026-04-02 · 15:45 CT · S406
    KEYNOTE-980: Keytruda (pembrolizumab) maintenance in metastatic melanoma
    C. Robert, P. Schmid, L. Paz-Ares, et al. · Memorial Sloan Kettering Cancer Center
    Oral Abstract SessionMelanoma📄🖼️🎬
  3. Abstract 96892026-04-04 · 16:30 CT · S406
    Opdivo plus chemotherapy in previously untreated metastatic melanoma: updated analysis from CheckMate-213
    E. Winer, A. Spira · Dana-Farber Cancer Institute
    Oral Abstract SessionMelanoma📄🖼️🎬
  4. Abstract 102102026-04-05 · 13:00 CT · E450
    CheckMate-757: Opdivo (nivolumab) 3L+ in metastatic melanoma
    P. Schmid, R. Herbst · Johns Hopkins Kimmel Cancer Center
    Oral Abstract SessionMelanoma📄🖼️🎬
  5. Abstract 104192026-04-03 · 14:00 CT · Hall B1
    Long-term follow-up of Opdivo 2L for metastatic melanoma: CheckMate-335
    S. Modi, R. Herbst, G. Curigliano, et al. · Cleveland Clinic
    Oral Abstract SessionMelanoma📄🖼️🎬
  6. Abstract 99202026-04-05 · 13:00 CT · Hall B1
    Long-term follow-up of Opdivo neoadjuvant for metastatic melanoma: CheckMate-368
    H. Rugo, N. Rizvi, T. Mok · Karolinska Institute
    Oral Abstract SessionMelanoma📄🖼️🎬
  7. Abstract 97532026-04-05 · 13:45 CT · S100A
    Biomarker subgroup analysis of Opdivo in metastatic melanoma (the CheckMate-602 study)
    C. Saura, M.C. Garassino · Royal Marsden Hospital
    Oral Abstract SessionMelanoma📄🖼️🎬
  8. Abstract 101652026-04-01 · 18:45 CT · E450
    CheckMate-515: Opdivo (nivolumab) maintenance in metastatic melanoma
    M. Reck, T. Mok · Karolinska Institute
    Oral Abstract SessionMelanoma📄🖼️🎬
  9. Abstract 99032026-04-05 · 18:00 CT · Arie Crown Theater
    Biomarker subgroup analysis of Keytruda in metastatic melanoma (the KEYNOTE-853 study)
    T. Mok, C. Robert, M.C. Garassino, et al. · National Cancer Center Japan
    Oral Abstract SessionMelanoma📄🖼️🎬
  10. Abstract 103662026-04-03 · 21:45 CT · S406
    KEYNOTE-818: Keytruda (pembrolizumab) neoadjuvant in metastatic melanoma
    S. Antonia, H. Borghaei · Stanford Cancer Institute
    Oral Abstract SessionMelanoma📄🖼️🎬
  11. Abstract 104872026-04-01 · 14:30 CT · E450
    Real-world effectiveness of Opdivo vs standard of care in metastatic melanoma
    S. Antonia, S. Modi, L. Paz-Ares, et al. · Stanford Cancer Institute
    Oral Abstract SessionMelanoma📄🖼️🎬
  12. Abstract 101002026-04-02 · 21:00 CT · S406
    Opdivo plus chemotherapy in previously untreated metastatic melanoma: updated analysis from CheckMate-657
    J. Cortes, P. Schmid, A. Spira, et al. · UCSF Helen Diller Family Comprehensive Cancer Center
    Oral Abstract SessionMelanoma📄🖼️🎬
  13. Abstract 102812026-04-04 · 21:45 CT · Hall B1
    Biomarker subgroup analysis of Opdivo in metastatic melanoma (the CheckMate-811 study)
    H. Borghaei, S. Modi, A. Spira · Mayo Clinic
    Oral Abstract SessionMelanoma📄🖼️🎬
  14. Abstract 102422026-04-04 · 20:15 CT · Hall B1
    Quality of life outcomes with Opdivo in patients with metastatic melanoma
    S. Antonia, S. Tolaney, M. Krop, et al. · National Cancer Center Japan
    Oral Abstract SessionMelanoma📄🖼️🎬
  15. Abstract 103212026-04-04 · 14:30 CT · S100A
    Keytruda plus chemotherapy in previously untreated metastatic melanoma: updated analysis from KEYNOTE-327
    C. Saura, S. Modi · UCSF Helen Diller Family Comprehensive Cancer Center
    Oral Abstract SessionMelanoma📄🖼️🎬
  16. Abstract 95172026-04-03 · 13:30 CT · E450
    Real-world effectiveness of Keytruda vs standard of care in metastatic melanoma
    G. Curigliano, R. Herbst, H. Rugo, et al. · Stanford Cancer Institute
    Oral Abstract SessionMelanoma📄🖼️🎬
  17. Abstract 95292026-04-02 · 13:30 CT · Hall B1
    Keytruda plus chemotherapy in previously untreated metastatic melanoma: updated analysis from KEYNOTE-763
    C. Robert, N. Rizvi, C. Saura, et al. · Memorial Sloan Kettering Cancer Center
    Oral Abstract SessionMelanoma📄🖼️🎬
© 2026 American Society of Clinical Oncology · Citations follow JCO supplement format:J Clin Oncol 44, 2026 (suppl 17; abstr XXXX). Demo mock.